Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Revenue (2020 - 2025)

Historic Revenue for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to $2.2 million.

  • Caribou Biosciences' Revenue rose 859.68% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year decrease of 1899.78%. This contributed to the annual value of $10.0 million for FY2024, which is 7101.26% down from last year.
  • Caribou Biosciences' Revenue amounted to $2.2 million in Q3 2025, which was up 859.68% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Revenue ranged from a high of $23.7 million in Q3 2023 and a low of $1.5 million during Q2 2021
  • Over the past 5 years, Caribou Biosciences' median Revenue value was $2.7 million (recorded in 2025), while the average stood at $4.0 million.
  • Per our database at Business Quant, Caribou Biosciences' Revenue surged by 61637.9% in 2023 and then tumbled by 9144.62% in 2024.
  • Quarter analysis of 5 years shows Caribou Biosciences' Revenue stood at $2.6 million in 2021, then soared by 44.28% to $3.7 million in 2022, then dropped by 3.63% to $3.6 million in 2023, then plummeted by 41.62% to $2.1 million in 2024, then grew by 5.83% to $2.2 million in 2025.
  • Its Revenue was $2.2 million in Q3 2025, compared to $2.7 million in Q2 2025 and $2.4 million in Q1 2025.